|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1215 K STREET, #700 |
Address2 |
|
City | SACRAMENTO |
State | CA |
Zip Code | 95814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 7747-12
|
||||||||
|
6. House ID# 334020000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Anne O'Rourke |
Date | 10/20/2023 11:26:49 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Q3 Lobbying Report (July 1-Sept 30)
HCR
Transparency (surprise medical bills; public posting of hospital charges)
340B Drug Pricing Program
Resident Physician Shortage Act of 2023 (H.R. 2389)
No Surprises Act regulations
Public Health Emergency designation
Food and Drug Amendments
No Surprise Bills for New Moms Act (H.R. 3387)
Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544)
Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (H.R. 3561)
Medicaid VBPs for Patients (MVP) Act (H.R. 2666)
Providers and Payers COMPETE Act (H.R. 3284)
To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (H.R. 3290)
Transparent PRICE Act (H.R. 3281/H.R. 2691))
Resident Physician Shortage Reduction (S. 1302)
Medical Student Education Authorization Act (H.R. 3046)
Save Americas Rural Hospitals Act (H.R. 833)
Chronic Care Management Improvement Act (H.R. 2829)
Safety From Violence for Healthcare Employees Act (H.R. 2584)
Supporting Safety Net Hospitals Act (H.R. 2665)
Patient Access to Higher Quality Health Care Act (H.R. 977/S.470)
FEMA re: COVID-19 related reimbursement
Public Health Guidance Transparency and Accountability Act of 2023 (H.R. 4529)
Public Health Emergency Congressional Review Act (H.R. 4381)
CDC Leadership Accountability Act of 2023 (H.R. 3813)
Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421)
Preparedness and Response Reauthorization Act (H.R. 4420)
Childrens Hospital GME Support Reauthorization Act of 2023 (H.R. 3887)
Health Care Price Transparency Act of 2023 (H.R. 4822)
Providers and Payers COMPETE Act (H.R. 3284)
Lower Costs, More Transparency Act (H.R. 5378
Transparency in Coverage Act (H.R. 4507)
MMM
Accelerated and Advance Payment Program repayment flexibility
Graduate Medical Education (GME) funding
Telehealth flexibilities and payment
Annual Prospective Payment System Rules
Organ acquisition payment policies
BUD
FY 2024 Appropriations bills
Nursing and allied health workforce funding
FY 2024 budget request
Submitted Comments
SUBJECT: CMS-1784-P, Medicare and Medicaid Program: CY 2024 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program, Federal Register (Vol. 88, No. 50), August 7, 2023
SUBJECT: CMS-1786-P, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Payment for Intensive Outpatient Services in Rural Health Clinics, Federally Qualified Health Centers, and Opioid Treatment Programs; Hospital Price Transparency; Changes to Community Mental Health Centers Conditions of Participation, Proposed Changes to the Inpatient Prospective Payment System Medicare Code Editor; Rural Emergency Hospital Conditions of Participation Technical Correction, Federal Register (Vol. 88, No. 145), July 31, 2023
Subject: 340B Program - Senate Request for Information
SUBJECT: CMS-5540-NC, Request for Information; Episode-Based Payment Model, Federal Register (Vol. 88, No. 136), July 18, 2023
SUBJECT: (CMS-1793-P) Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022; Federal Register (Vol. 88, No. 131), July 11, 2023
SUBJECT: CMS-1780-P, Medicare Program; Calendar Year (CY) 2024 Home Health (HH) Prospective Payment System Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin Items and Services; Hospice Informal Dispute Resolution and Special Focus Program Requirements, Certain Requirements for Durable Medical Equipment Prosthetics and Orthotics Supplies; and Provider and Supplier Enrollment Requirements; Federal Register (Vol. 88, No. 130), July 10, 2023
Comments re: Application and Employment Certification for Public Service Loan Forgiveness (Agency/Docket no. ED-2023-SCC-0079; Docket ID no. 2023-10191)
SUBJECT: CMS-2434-P, Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program; Proposed Rule, Federal Register (Vol. 88, No. 102), May 26, 2023
SUBJECT: CMS-2439-P, Medicaid Program; Medicaid and Children's Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality; Proposed Rule, Federal Register (Vol. 88, No. 85), May 3, 2023
SUBJECT: CMS-2442-P, Medicaid Program; Ensuring Access to Medicaid Services; Proposed Rule, Federal Register (Vol. 88, No. 85), May 3, 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anne |
O'Rourke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |